Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Cash & Current Investments (2016 - 2025)

Metlife (MET) has 17 years of Cash & Current Investments data on record, last reported at $9.7 billion in Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 41.95% year-over-year to $9.7 billion; the TTM value through Dec 2025 reached $11.9 billion, down 52.7%, while the annual FY2024 figure was $25.2 billion, 178.23% up from the prior year.
  • Cash & Current Investments reached $9.7 billion in Q3 2025 per MET's latest filing, down from $22.2 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $26.6 billion in Q1 2022 and bottomed at $4.8 billion in Q1 2021.
  • Average Cash & Current Investments over 5 years is $15.6 billion, with a median of $16.1 billion recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: plummeted 80.16% in 2021, then soared 457.08% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $9.1 billion in 2021, then tumbled by 31.87% to $6.2 billion in 2022, then skyrocketed by 45.64% to $9.1 billion in 2023, then soared by 178.23% to $25.2 billion in 2024, then tumbled by 61.54% to $9.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $9.7 billion in Q3 2025, $22.2 billion in Q2 2025, and $21.3 billion in Q1 2025.